1. Sloka S, Silva C, Wang J, Yong V W. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation 2011; 8:56.
3. Kidd P
. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev
4. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23:683-747.
5. Begolka WS
, Vanderlugt CL
, Rahbe SM
, Miller SD
. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 1998; 161:4437-4446.
7. Issazadeh S
, Ljungdahl A
, Höjeberg B
, Mustafa M
, Olsson T
. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol 1995; 61:205-212.
10. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett
12. Van der Mei IA
, Ponsonby AL
, Blizzard L
, Dwyer T
. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20:168-174.
14. Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. Sunlight, dietary factors and epidemiology. Int J Environ Stud 1974; 6:19-27.
15. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008; 194:7-17.
18. Rausch-Fan X, Leutmezer F, Willheim M, Spittler A, Bohle B, Ebner C, et al. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol 2002; 128:33-41.
19. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev 1998; 9:139-151.
20. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996; 17:138-146.
21. Begolka WS
, Miller SD
. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res Immunol 1998; 149:771-781.
22. Brosnan CF
, Cannella B
, Battistini L
, Raine CS
. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 1995; 45:S16-S21.
23. Akassoglou K
, Bauer J
, Kassiotis G
, Pasparakis M
, Lassmann H
, Kollias G
, et al.
Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998; 153:801-813.
25. Cammer W
. Protection of cultured oligodendro-cytes against tumor necrosis factor-alpha by the antioxidants coenzyme Q (10) and N-acetyl cysteine. Brain Res Bull.
26. Garcion E, Sindji L, Nataf S, Brachet P, Darcy F, Montero-Menei CN. Treatment of experimental autoimmune encephalomyelitis in rat by 1, 25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol 2003; 105:438-448.
27. Cantorna M. Vitamin D and its role in immunology: multiple sclerosis and inflammatory bowel disease. ProgBiophysMolBiol 2006; 92:60-64.
28. Van Amerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr
29. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxy vitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86:888–894.
30. Eyles D, Brown J, Mackay-Sim A, McGrath J,Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118:641-653.
31. Garcion E, Nataf S, Berod A, Darcy F, Brachet P. 1,25- Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Mol Brain Res 1997; 45:255-267.
32. Nashold FE, Hoag KA, Goverman J, Hayes CE. Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001; 119:16-29.
33. Muthian G, Raikwar HP, Rajasingh J, Bright JJ. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgama axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83:1299-1309.
34. Nashold F, Miller D, Hayes C.1,25-Dihydroxyvitamin D treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol
35. Mosayebi G, Ghazavi A, Payani MA. The effect of vitamin D3 on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. RJMS 2006; 13:189-196
36. Ghazavi A
, Mosayebi G
. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice. Phytother Res
2012; 26: 34-38.
37. Wergeland S, Torkildsen O, Myhr K-M, Aksnes L, Mork SJ. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One 2011; 6:e26262.